Harrow | search
Click here to view Harrow news from 60+ newspapers.
Bookmark or Share- About - HarrowWe make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions.
- Investor Relations | Harrow, Inc.Harrow, Inc. (NASDAQ: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable.
- Products - HarrowHarrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is directly tied to our unique approach to serving patients and supporting eyecare professionals.
- HarrowWe make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions.
- Careers - HarrowAre you ready to embark on an exciting and rewarding journey that combines innovation, collaboration, and growth? We are looking for passionate individuals to explore the limitless opportunities within the Harrow Family.
More
